Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Freegold Ventures Limited – Results of the Annual General and Special Meeting June 28, 2025 Top 5 Canadian Mining Stocks This Week: Onyx Gold Shines with 118 Percent Gain June 28, 2025 Platinum Price Surges to 11 Year High, Breaks US$1,400 June 28, 2025